NLRP3 INHIBITOREN

European patent · EP4337652 · In force

Register entry

Publication number
EP4337652
Application number
EP22728228
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 10, 2022
Published
Mar 20, 2024
Granted
Apr 9, 2025
Protection ends at the latest
May 9, 2042
Next annual fee due
May 31, 2027
IPC classes
C07D 401/12 (2006.01)
C07D 403/12 (2006.01)
C07D 405/14 (2006.01)
C07D 471/08 (2006.01)
A61P 11/06 (2006.01)
A61K 31/53 (2006.01)
Priority
EP 21173452 12.05.2021
EP 21209447 22.11.2021
EP 21215859 20.12.2021
PCT application
PCT/EP2022/062525 10.05.2022
PCT publication
WO2022/238347 17.11.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 1, 2026

    Change

    Published in Swissreg on 01.06.2026

  2. Feb 18, 2026

    Change

    Published in Swissreg on 18.02.2026

  3. Jun 1, 2025

    Change

    Published in Swissreg on 01.06.2025

  4. Apr 9, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 09.04.2025

Parties

Holder

F. Hoffmann-La Roche AG

Grenzacherstrasse 124, 4070 Basel

Inventor

BOUCHE, Lea Aurelie

4070 Basel

GUBA, Wolfgang

4070 Basel

JAESCHKE, Georg

4070 Basel

MESCH, Stefanie Katharina

4070 Basel

TOSSTORFF, Andreas Michael

4070 Basel

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.